PRGO241220P17500
- 0.02
- 0.000.00%
Perrigo Newsroom
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Perrigo to Get $98 Million From D&O Insurers Over Investor Lawsuit
Express News | Perrigo: Upon Payment Received, to Surrender 2015 & 2016 Policies & Withdraw Claims Related to Securities Litigation Under 2017 & 2018 Policies
Express News | Perrigo Co PLC - Reaches Settlement Agreement With Insurers
Independent Director Jeffrey Kindler Sold A Bunch Of Shares In Perrigo
Insider Sale: Director at $PRGO (PRGO) Sells 17,598 Shares
Perrigo (PRGO) Up 5.6% Since Last Earnings Report: Can It Continue?
Wolfe's Short Ideas: Companies With Potential Dividend Cuts
Perrigo To Go Ex-Dividend On November 29th, 2024 With 0.276 USD Dividend Per Share
Perrigo Insiders Sold US$1.6m Of Shares Suggesting Hesitancy
US Manufacturing Index Rises To 43, Highest Since 2020
Perrigo (PRGO) International Revenue Performance Explored
CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42
Perrigo (NYSE:PRGO) Is Paying Out A Dividend Of $0.276
Perrigo | 10-Q: Q3 2024 Earnings Report
Perrigo Company Plc (PRGO) Q3 2024 Earnings Call Transcript Summary
Perrigo Company Plc (PRGO) Q3 2024 Earnings Call Transcript
Perrigo's Q3 Earnings Fall Short of Estimates, Sales View Updated
Perrigo | 8-K/A: Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations
Press Release: /C O R R E C T I O N -- Perrigo Company Plc/